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INTRODUCTION 
Varicose veins affect 10-20 percent of the population  and about 
2% have skin changes which may precede venous ulceration. Varicose 
veins recognized since biblical times. The use of compression therapy 
dates back to Roman times, soldiers using tight wraps to reduce the 
discomfort due to prolonged standing. 
However, our modern understanding of varicose veins did not arise 
until the work of Brodie and Trendelenburg in the 1850s and 1890s 
Trendelenburg was credited with introducing surgery for varicose 
veins, thus marking the beginning of modern vascular surgery for this 
problem. 
Surgery is still the best and reliable therapeutic option for treatment 
of varicose veins. High ligation, stripping and excision/ligation of 
varicose veins is a procedure that was introduced at the turn of 19 th to 
20th century. 
Reported rates of recurrence of the disease after treatment of 
superficial varicose veins range from 7-65 percent.Stripping of long 
saphenous vein only in the thigh reduces the incidence of nerve injury 
and reduces the incidence of recurrence by ensuring the avulsion of 
potential perforating veins. 
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Endovenous ablation has replaced stripping and ligation as the 
technique for elimination of saphenous vein reflux. One of the 
endovenous techniques is a radiofrequency-based procedure. Newer 
methods of delivery of radiofrequency were introduced in 2007. 
Endovenous procedures are far less invasive than surgery and have lower 
complication rates. The procedure is well tolerated by patients, and it 
produces good cosmetic results. 
Therefore, it was intended to undertake a study to compare long 
saphenous vein stripping from groin to knee, high saphenofemoral 
junction ligation and radiofrequency ablation in the treatment of varicose 
veins with saphenofemoral incompetence. 
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AIM OF THE STUDY 
 
1. To compare the effectiveness of each treatment  
2. To compare the complications involved in various 
procedures 
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REVIEW OF LITERATURE 
EPIDEMIOLOGY 
The  prevalence of varicose veins is around 5%- 30% in the adult 
population, but reports have ranged from less than 1% to greater than 
70%. The prevalence  is higher in developed, industrial countries than in 
underdeveloped countries. 
Most studies found a greater prevalence of varicose veins in 
females, with an approximate twofold predominance, but this was not 
universal. In contrast, other studies, including the Edinburgh Vein Study, 
reported a greater prevalence of varicose veins in men than in women. 
The apparent female predilection has been presumed to be due to 
the effect of pregnancy and possibly hormonal influences. Numerous 
other risk factors are associated with the development of varicose veins, 
including old age, family history, obesity and a standing occupation. 
Additional behavioral factors such as smoking, physical inactivity, and 
low-fiber diets also suggested to play a role. 
ANATOMY 
To determine the pathology, detail knowledge of venous anatomy 
is essential. After the location and type of venous incompetence have 
known, a treatment option can be planned. Venous drainage of the legs is 
the  function  of  two  parallel  and  connected  systems,  the  deep  and  
superficial systems. 
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Superficial Venous System 
The superficial veins of  lower extremity form a network that 
connects the superficial dorsal veins of foot and deep plantar veins. The 
dorsal venous arch, into which empty the dorsal metatarsal veins, is 
continuous with the GSV medially and the SSV laterally. 
The great saphenous vein, in close proximity to saphenous nerve, 
ascends anterior to medial malleolus, crosses and then medial to the knee. 
It ascends in superficial compartment and empties into the common 
femoral vein after entering the fossa ovalis. 
Before entering into the common femoral vein, GSV receives 
medial and lateral accessory saphenous veins, as well as small tributaries 
from the inguinal region, pudendal region, and anterior abdominal wall 
The posterior arch vein drains the area around medial malleolus 
and, as it ascends up the posterior medial aspect of the calf, it receives 
medial perforating veins, termed Cockett’s perforators, before joining the 
great saphenous vein at or below the knee. 
The small saphenous vein arises from dorsal venous arch at lateral 
aspect of the foot and ascends posterior to lateral malleolus, rising 
cephalad in the  midposterior calf. 
The small saphenous vein continues to ascend, penetrates the 
superficial fascia of the calf, and then terminates into the popliteal vein. 
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The exact entry of the small saphenous vein into the popliteal vein is 
variable. The sural nerve lies parallel to the small saphenous vein. 
Perforating Venous System 
Perforating veins connect superficial venous system to deep venous 
system by penetrating fascial layers of the lower extremity. These 
perforators run in a perpendicular fashion to the axial veins.Although the 
total number of perforator veins is variable, up to 100 have been 
documented. 
The perforators enter at various points in the leg—the foot, medial 
and lateral calf, and mid and distal thigh. Some have been named 
Cockett’s perforators, which connects posterior arch and posterior tibial 
veins, Boyd’s perforators, which connects  great saphenous and 
gastrocnemius veins, and Hunterian and Dodd’s perforators, which 
connect the great saphenous and superficial femoral veins. 
The valve system of perforators aids in preventing reflux from the 
deep to the superficial system, particularly during periods of standing and  
ambulation. 
Normal Venous Histology and Function 
The venous wall is composed of 3 layers, the intima, media, and 
adventitia. Vein walls have less smooth muscle and elastin than their 
arterial counterparts. The venous intima has an endothelial cell layer 
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resting on a basement  membrane. The media is composed of smooth 
muscle cells and elastin connective tissue. The adventitia of the venous 
wall contains adrenergic fibers, particularly in the cutaneous veins. 
The histologic features of veins vary, depending on the caliber of 
veins. The venules, range from 0.1 to 1 mm and contain mostly smooth 
muscle cells, whereas the larger extremity veins contain relatively few 
smooth muscle cells. These larger caliber veins have less contractile 
capacity in comparison to thicker walled great saphenous vein. The 
venous valves prevent retrograde flow; their failure or valvular 
incompetence that leads to reflux and its associated symptoms. Venous 
valves are most prevalent in the distal lower extremity, whereas as one 
proceeds proximally, the number of valves decreases to the point that no 
valves are present in the superior vena cava and inferior vena cava.  
Most of the capacitance of the vascular tree is in the venous 
system. Because veins do not have significant amounts of elastin, veins 
can withstand large volume shifts with comparatively small changes in 
pressure. 
A vein has a normal elliptical configuration until the limit of its 
capacitance is reached, at which point the vein assumes a round 
configuration. 
The calf muscles augment venous return by functioning as a pump. 
The return of blood to heart from the lower extremity is facilitated by 
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muscle pump function of the calf, a mechanism whereby the calf muscle, 
functioning as a bellows during exercise, compresses the gastrocnemius 
and soleal sinuses and propels the blood towards the heart. 
During calf muscle contraction, the venous pressure of the foot and 
ankle drop dramatically. The pressures developing in the muscle 
compartments during exercise range from 150 to 200 mm Hg and, when 
there is failure of perforating veins, these high pressures are transmitted 
to the superficial system. 
VENOUS INSUFFICIENCY 
There are three categories of venous insufficiency-congenital, 
primary, and secondary Congenital venous insufficiency is comprised 
of anatomic variants that are present at birth. Examples include venous 
ectasias, absence of venous valves, and syndromes such as Klippel-
Trenaunay syndrome. 
Primary venous insufficiency is an acquired idiopathic entity. 
This is the largest clinical category and represents most of the superficial 
venous insufficiency encountered in the office. 
Secondary venous insufficiency arises from a post-thrombotic or 
obstructive state and is caused by a deep vein thrombus or primary 
chronic obstructive process. 
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Primary Venous Insufficiency 
There are three main anatomic categories of primary venous 
insufficiency-telangiectasias, reticular veins, and varicose veins. 
Telangiectasias, reticular varicosities, and varicose veins are similar but 
exhibit distinct variations in caliber. 
Telangiectasias are small intradermal venules that are too 
diminutive to demonstrate reflux. Reticular veins are vein branches that 
enter the tributaries of the main axial, perforating, or deep veins. 
The axial veins, the great or small saphenous veins, represent the 
largest caliber veins of the superficial venous system. 
Pathology 
The precise pathology of venous insufficiency has yet to be 
elucidated. Here we describe some of the areas in which research has 
started to reveal its multifactorial pathogenesis. 
Mechanical Abnormalities 
Anatomic differences in location of the superficial veins of the 
lower extremities may contribute to pathogenesis. Primary venous 
insufficiency may involve both axial veins (great and small saphenouss), 
either, or neither. 
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Perforating veins may be the sole source of venous pathology, 
perhaps because the GSV is supported by a well-developed medial 
fibromuscular layer and fibrous connective tissue that bind it to the deep 
fascia. 
In contrast, tributaries to SSV are less supported in the 
subcutaneous fat and are superficial to the membranous layer of 
superficial fascia. These tributaries also contain less muscle mass in their 
walls. Thus, these veins,  may become selectively varicose. 
When these fundamental anatomic peculiarities are recognized, the 
intrinsic competence or incompetence of the valve system becomes 
important. For example, failure of a valve protecting a tributary vein from 
the pressures of the small saphenous vein allows a cluster of varicosities 
to develop. 
Furthermore, communicating veins connecting the deep with the 
superficial compartment may have valve failure. 
Venous Hypertension 
Studies have shown that there are two sources of venous 
hypertension. The first is gravitational, which is a result of venous blood 
coursing in a distal direction down linear axial venous segments. This is 
referred to as hydrostatic pressure and is the weight of the blood column 
from the right atrium. The highest pressure generated by this mechanism 
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is evident at the ankle and foot, where measurements are expressed in 
centimeters of water or millimetres of mercury. 
The second source of venous hypertension is dynamic. It is the 
force of muscular contraction, usually contained within the compartments 
of the leg. 
If a perforating vein fails, high pressures (range, 150 to 200 mm 
Hg) developed within the muscular compartments during exercise are 
transmitted directly to the superficial venous system. Here, the sudden 
pressure transmitted causes dilation and lengthening of the superficial 
veins. Progressive distal valvular incompetence may occur. 
If proximal valves such as the saphenofemoral valve become 
incompetent, systolic muscular contraction is supplemented by the weight 
of the static column of blood from the heart. Furthermore, this static 
column becomes a barrier. 
Blood flowing proximally through the femoral vein spills into the 
saphenous vein and flows distally. As it refluxes distally through 
progressively incompetent valves, it is returned through perforating veins 
to the deep veins. Here, it is conveyed once again to the femoral veins, 
only to be recycled distally. 
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Cellular Abnormalities 
Changes also occur at cellular level. Angioscopic observation 
demonstrates monocytic and macrophage infiltration in those vein valves 
affected by venous insufficiency. 
 In regions of chronic advanced venous insufficiency, such as 
advanced lipodermatosclerosis, capillary proliferation is seen and 
extensive capillary permeability occurs as a result of widening of 
interendothelial cell pores. Transcapillary leakage of osmotically active 
particles occurs, mainly of fibrinogen. In chronic venous insufficiency, 
venous fibrinolytic capacity is diminished and the extravascular fibrin 
remains to prevent the normal exchange of oxygen and nutrients in the 
surrounding cells. However, little proof exists for an actual abnormality 
in the delivery of oxygen to the tissues. 
Molecular Abnormalities 
On a molecular level, several abnormalities identified in 
extremities that manifest venous hypertension. Varicose veins 
demonstrate less amounts of elastin and collagen, suggesting a 
contributing role toward venous pathology. 
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Risk Factors 
Risk factors for the development of varicose veins include 
advancng age, female gender, heredity, and history of trauma to the 
extremity. Venous function is undoubtedly influenced by hormonal 
changes. 
Symptoms 
Venous valvular dysfunction causes venous hypertension and, as 
such, patients’ symptoms are attributed to excess venous pooling. The 
patient with symptomatic varicose veins commonly reports heaviness, 
discomfort, and extremity fatigue. 
The pain is characteristically dull, does not usually occur during 
recumbency or early in morning, and is exacerbated in afternoon, 
especially after periods of prolonged standing. Swelling is commonly 
described. The discomforts of aching, heaviness, and/or fatigue are 
usually relieved by leg elevation or elastic support. 
Cutaneous burning, termed venous neuropathy, can also occur in 
patients with advanced venous insufficiency. Pruritus occurs from 
excess hemosiderin deposition and tends to be located at the distal calf or 
in areas of phlebitic varicose branch segments. 
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Physical Examination 
A comprehensive examination includes assessment of the arterial 
circulation. Briefly, palpation of the femoral, popliteal, dorsalis pedis, and 
posterior tibialis pulses is performed. 
Auscultation of pulse flow is indicated when a thrill or widened 
pulse is appreciated. Demonstration of decreased hair, dependent rubor, 
pallor on 
elevation, and tissue loss are all indicative of advanced arterial 
ischemia. 
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The venous examination includes assessment of the patient in the 
standing and supine positions. Standing increases venous hypertension 
and dilates veins, thereby facilitating examination. 
Patients with superficial axial incompetence commonly exhibit 
palpable great saphenous veins. Palpable cords may be present. Visual 
inspection is critical. Signs of advanced venous insufficiency include 
hyperpigmentation in the gaiter distribution, secondary to hemosiderin 
deposition, and lipodermatosclerosis. Lipodermatosclerosis develops over 
time, due to prolonged ambulatory venous hypertension and chronic 
inflammation. 
Physical examination findings that reflect lipodermatosclerosis are: 
brawny edema of the distal calf, “champagne bottle leg,” fibrotic, 
hypertrophic skin, and hyperpigmentation. Advanced 
lipodermatosclerosis may involve fibrosis of the Achilles tendon, 
impairing motor function of the extremity. 
Corona phlebectica is a term used to describe an accumulation of 
tiny telangiectasias or venous flare, usually located at the medial 
malleolus. Venous stasis ulcers exhibit pathognomonic features that 
distinguish them from their arterial or neuropathic counterparts. Venous 
ulcers are not generally painful and appear at the malleolus, not in the 
mid to distal foot. 
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Venous ulceration located proximal to the medial malleolus 
Lack of arterial pulses in patients with a venous ulcer is unusual. 
Venous stasis dermatitis is visualized at the distal ankle and can mimic 
eczema  or  dermatitis  of  another  cause.  It  is  this  important  attention  to  
supporting features of the physical examination and history, as well as 
confirmation with duplex reflux examination, that will distinguish 
advanced venous stasis disease from dermatologic conditions. 
Diagnostic Evaluation of Venous Dysfunction 
The Perthes test for deep venous occlusion and Brodie- 
Trendelenburg test of axial reflux have been replaced by in-office use of 
the continuous wave, hand-held Doppler instrument supplemented by 
duplex evaluation. 
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The hand-held Doppler can confirm an impression of saphenous 
reflux, which in turn dictates the operative procedure to be performed in a 
given patient. A common misconception is the belief that the Doppler 
instrument is used to locate perforating veins. Instead, it is used in 
specific locations to determine incompetent valves—for example, the 
hand-held, continuous wave, 8-MHz flow detector placed over the greater 
and lesser saphenous veins near their terminations. With distal 
augmentation of flow and release, normal deep breathing, and 
performance of a Valsalva maneuver, valve reflux is accurately 
identified. 
Duplex technology more precisely defines which veins are 
refluxing by imaging the superficial and deep veins. The duplex 
examination is commonly done with the patient supine, but this yields an 
erroneous evaluation of reflux. In the supine position, even when no flow 
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is present, the valves remain open. Valve closure requires a reversal of 
flow with a pressure gradient that is higher proximally than distally. 
Thus, the duplex examination needs to be done with the patient standing 
or in the markedly trunk-elevated position. Imaging is obtained with a 
7.5- or 10-MHz probe; the pulsed Doppler consists of a 3.0-MHz probe. 
The patient stands, with the probe placed longitudinally on the groin. 
After imaging, sample volumes can be obtained from the femoral and 
saphenous veins. This flow can be observed during quiet respiration or 
distal augmentation. Sudden release of augmentation allows the 
assessment of valvular competence. The small saphenous vein and 
popliteal veins are similarly examined. Reflux times of 3 seconds or 
longer is considered significant. 
Perforator veins can be visualized with duplex examination. 
Demonstration of duplex images of to and fro flow, with the presence of 
dilated segments, constitutes findings compatible with a refluxing 
perforator. Additionally, Doppler studies can provide the clinician with 
information about the deep system. Widespread use of duplex scanning 
has allowed a comparison of findings between standard clinical 
examinations and duplex Doppler studies. 
Phlebography and Venography 
Phlebography is unnecessary in diagnosis and treatment of primary 
venous insufficiency. In cases of secondary chronic venous insufficiency, 
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phlebography has specific usefulness. Ascending phlebography is 
performed via injection of contrast into a superficial pedal vein  after a 
tourniquet is applied at the ankle to prevent flow into the superficial 
venous system. Observation of flow indicates defines anatomy and 
regions of thrombus or obstruction. Therefore, ascending phlebology 
differentiates primary from secondary venous insufficiency. 
Descending phlebography is performed with retrograde injection of 
contrast into deep venous system at groin or popliteal fossa. This 
diagnostic modality identifies specific valvular incompetence suspected 
on B mode scanning and clinical examination. These studies are only 
performed as preoperative adjuncts when deep venous reconstruction is 
being planned. 
Magnetic Resonance Venous Imaging 
Magnetic resonance venous imaging  is a diagnostic imaging 
modality reserved for evaluation of abdominal and pelvic venous 
vasculature. MRVI, unlike venography, is noninvasive and does not 
require IV contrast.  Furthermore, studies have documented similar rates 
of specificity and sensitivity when compared with venography. MRVI is 
used for the evaluation of congenital malformations and identification of 
chronic and acute venous thrombi. 
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CLASSIFICATION SYSTEMS 
American Venous Forum devised the CEAP classification system,  
a scoring system that stratifies venous disease based on clinical 
presentation, etiology, anatomy, and pathophysiology. 
A revised CEAP was introduced which included a venous 
disability score to document a patient’s ability to perform activities of 
daily living. 
Although the CEAP classification is a valuable tool to grade 
venous disease, assessment of outcomes following intervention cannot be 
realized. As a result, two additional scoring systems, the venous clinical 
severity scoring system (VCSS) and venous segmental disease score 
(VSDS), enhance the CEAP score with the increased ability to plot 
outcome. These three  classification modalities  provide clinicians with 
invaluable tools to study treatment outcomes. 
Classification of Chronic Lower Extremity Venous Disease 
C Clinical signs (grade0-6), supplemented by “A” for 
asymptomatic and “S” for symptomatic presentation 
E  by Etiology - congenital, primary, secondary 
A Anatomic distribution -  superficial, deep, or perforator, alone 
or in combination 
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P Pathophysiologic dysfunction - reflux or obstruction, alone or 
in combination. 
Clinical Classification (C0-6) 
Any limb with possible chronic venous disease is first placed into 
one of seven clinical classes (C0-6), according to the objective signs of 
disease. 
Clinical Classification of Chronic Lower Extremity Venous Disease* 
CLASS FEATURES 
0 No visible or palpable signs of venous disease 
1 Telangiectasia, reticular veins, malleolar flare 
2 Varicose veins 
3 Edema without skin changes 
4 Skin changes ascribed to venous disease (e.g., pigmentation, 
venous eczema, lipodermatosclerosis) 
5 Skin changes as defined above with healed ulceration 
6 Skin changes as defined above with active ulceration 
 
Limbs in higher categories have more severe signs of chronic 
venous disease and may have some or all of the findings defining a less 
severe clinical category. Each limb is further characterized as 
asymptomatic (A)—for example, C0-6,A—or symptomatic (S)—for 
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example, C0-6,S. Symptoms that may be associated with telangiectatic, 
reticular, or varicose veins include lower extremity aching, pain, and skin 
irritation. Therapy may alter the clinical category of chronic venous 
disease. Limbs should therefore be reclassified after any form of medical 
or surgical treatment. 
Classification by Cause 
Venous dysfunction may be congenital, primary, or secondary. 
These categories are mutually exclusive. Congenital venous disorders are 
present at birth but may not be recognized until later. The method of 
diagnosis of congenital abnormalities must be described. Primary venous 
dysfunction is defined as venous dysfunction of unknown cause but not 
of congenital origin. Secondary venous dysfunction denotes an acquired 
condition resulting in chronic venous disease - for example, deep venous 
thrombosis. 
Classification by Cause of Chronic Lower Extremity Venous Disease 
Congenital (EC) Cause of the chronic venous disease present 
since birth. 
Primary (EP) Chronic venous disease of undetermined cause. 
Secondary (ES) Chronic venous disease with an associated known 
cause (e.g., post-thrombotic, post-traumatic, other). 
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Anatomic Classification (AS, AD, or AP) 
The anatomic site of the venous disease should be described as 
superficial (AS), deep (AD), or perforating (AP) vein(s). One, two, or 
three systems may be involved in any combination. For reports requiring 
greater detail, the involvement of the superficial, deep, and perforating 
veins may be localized by use of the anatomic segments. 
Segmental Localization of Chronic Lower Extremity Venous Disease 
SEGMENT NO. VEIN(s) 
Superficial Veins (AS1-5) 
1  Telangiectasia/reticular veins 
Greater (long) saphenous vein 
2  Above knee 
3  Below knee 
4  Lesser (short) saphenous vein 
5  Nonsaphenous 
Deep Veins (AD6-16) 
6  Inferior vena cava 
ILIAC 
7  Common  
8  Internal 
9  External 
10  Pelvic: gonadal, broad ligament 
FEMORAL 
11  Common 
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Treatment of Superficial Venous Insufficiency 
Nonoperative Management as noted, symptoms of primary venous 
insufficiency are manifestations of valvular incompetence. Therefore, the 
objective of conservative management is to improve the symptoms 
caused by venous hypertension. The first measure is external compression 
using elastic hose, 20 to 30 mm Hg, to be worn during the daytime hours. 
Although the exact mechanism whereby compression is of benefit is not 
entirely known, a number of physiologic alterations have been observed 
with compression. These include reduction in ambulatory venous 
pressure, improvement in skin microcirculation, and increase in 
subcutaneous pressure. Patients are instructed to wear the bandage during 
the  day  only,  but  to  put  the  stockings  on  as  soon  as  the  day  begins;  
swelling with standing will make stocking placement difficult. Care must 
be taken with patients who have concomitant arterial insufficiency 
because the compression stockings may exacerbate arterial outflow to the 
foot. Therefore, these patients require less compression-in some cases no 
compression whatsoever - depending on the severity of the arterial 
disease. 
The second part of conservative therapy is to practice lower 
extremity elevation for two brief periods during the day, instructing the 
patient that the feet must be above the level of the heart. With good 
compliance, these measures may ameliorate symptoms so that patients 
may not require further intervention. 
25 
 
Third, patients are encouraged to  participate in activities that 
activate the calf musculovenous pump, thereby decreasing ambulatory 
venous hypertension. These activities include frequent ambulation and 
exercise. Patients who exhibit venous stasis ulceration will require local 
wound care. A triple-layer compression dressing, with zinc oxide paste 
gauze wrap in contact with the skin, is used commonly, from the base of 
the toes to the anterior tibial tubercle with snug graded compression. This 
is an example of what is generally known as an Unna boot. 
Indications for interventional treatment are symptoms refractory to 
conservative therapy, recurrent superficial thrombophlebitis, variceal 
bleeding, and venous stasis ulceration. 
SURGICAL TECHNIQUES 
Surgery for varicose veins should be individualized according to 
patient's preop evaluation. A combination of ligation, axial stripping, and 
stab phlebectomy may be applied as needed to the GSV, SSV, tributary 
veins, and perforating veins.  
After preoperative evaluation and elucidation of the necessary 
scope of surgery, a decision will be made regarding the appropriate 
method of anesthesia and site of service. Preoperative marking of the 
patient in the standing position with an indelible marker is important in 
any case in which stab phlebectomy or direct perforator ligation is 
contemplated. Such marking is essential because visualization of varicose 
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tributaries may be impossible once the patient is prepared and the leg 
elevated. Patients are to be shaved immediately preoperatively with a 
clipper and the leg cleansed with an appropriate surgical preparation. 
HIGH LIGATION OF THE GREAT SAPHENOUS VEIN 
The GSV is most easily approached through an oblique incision 
1 cm below and parallel to the groin crease. This location provides the 
best cosmetic results and the most reliable access to the saphenofemoral 
junction. Some surgeons, however, recommend an incision right in the 
groin crease. The incision should start over the palpable femoral artery 
and extend medially to balance the better cosmesis of limited incisions 
with the necessity to ensure appropriate visualization of the 
saphenofemoral junction and its tributaries. 
Preoperative DUS-guided marking of the saphenofemoral junction 
further improves the precision of incision placement and allows minimal 
incision size and subcutaneous dissection. As the subcutaneous tissue is 
split, the main trunk of the GSV is identified. A self-retaining retractor is 
helpful, and the plane over the saphenous vein is extended toward the 
saphenofemoral junction. This anterior plane is generally free of 
encumbrances and allows exposure to the junction. Each of the tributaries 
is divided and ligated because the SFJ needs to be clearly identified. 
Failure to clearly define the saphenofemoral junction has resulted in 
disastrous injuries to the femoral vein or artery. 
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There are six main tributaries joining the GSV near its termination. 
However, the number and position of these tributaries highly varies, and 
therefore it is necessary to dissect the femoral vein 2 cm above and below 
the confluence to be sure that no additional tributaries join the femoral 
vein directly. Lateral and medial accessory saphenous veins may enter the 
main trunk between 2 and 20 cm below the confluence.  
When stripping is planned, these distal tributaries are avulsed, but 
if ligation alone is planned, the dissection should be extended caudad for 
approximately 10 cm to ensure division of these hidden tributaries. High 
ligation of the GSV is performed close to the femoral vein. Double 
ligation performed on a proximal stump with the second ligation being a 
suture ligature. Care should be taken to avoid narrowing the femoral vein. 
Equally important is to avoid leaving a long stump with a risk for 
thrombus formation and potential embolism. If high ligation alone is to be 
performed, one should resect the segment of GSV exposed in the surgical 
field, generally 5 to 10 cm in length.  
The incision is closed in layers by approximating the subcutaneous 
tissue with absorbable suture and the skin with absorbable subcuticular or 
interrupted nylon suture. 
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Great Saphenous Vein Stripping 
GSV stripping is the central component of classic operation for 
varicose veins. Recurrence rates are markedly reduced when the GSV is 
stripped as opposed to performing high ligation alone, therefore high 
ligation is usually performed in conjunction with treatment of the GSV. 
During preoperative marking for L&S of the GSV, the surgeon should 
review the extent and distribution of reflux disease in the saphenous 
system. The GSV in the thigh is incompetent in only about two thirds of 
patients undergoing surgery for symptomatic varicose veins. In addition, 
unless the caudal below-knee saphenous vein is obviously incompetent 
and varicose, there is no need to remove it. 
After flush ligation is performed, a transverse venotomy is created 
and a stripper is passed distally. In most cases the presence of reflux 
allows easy passage of the stripper to the level of the knee. A second 
small incision is made over the palpable stripper near the knee. The 
caudal incision is made transversely and the subcutaneous tissues 
dissected to allow recovery of the saphenous vein. This top-down passage 
of the stripper not only facilitates identification of the saphenous vein at 
the knee and allows a small lower incision to be made but also avoids the 
potential for the stripper passed from below to enter the femoral vein 
through a thigh perforator and cause the femoral vein to be mistaken for 
the saphenous vein. The GSV should be stripped in a downward 
direction, which results in improved avulsion of tributaries and 
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diminished injuries to the saphenous nerve. To avulse the vein with the 
endoluminal stripper one needs to affix the catheter to the most cephalic 
portion of the vein. This may be accomplished by attaching the classic 
stripper head to the top of the disposable stripper after first placing a silk 
ligature around the vein and the stripper just below the head. Using the 
smallest head size minimizes tissue injury and bruising, whereas a larger 
head size will improve one's chance of recovering the entire vein and the 
tributary segments. 
A long trailing silk suture is initially attached at the stripper head 
and  drawn through  the  tunnel  with  the  vein.  After  all  the  tributaries  are  
avulsed and the caudal GSV divided and ligated, the vein is drawn back 
up to the groin incision, thereby minimizing the distal incision. 
Although many variations of this technique have been described, 
the most common alternative approach involves invagination of the GSV 
into itself. This technique may be performed with a disposable plastic 
Codman Vein Stripper without attaching a stripper head but instead 
intussuscepting the vein. Alternatively, a reusable metal cannula may be 
used in a similar fashion. This technique minimizes the diameter of tunnel 
created by vein removal in an effort to diminish local trauma to soft 
tissues and nerves. However, the saphenous vein is susceptible to tearing 
at the sites of tributary confluence and thus could result in incomplete 
stripping of the target vein. Consequently, when the vein is removed, it 
should be unfurled and compared with the planned treatment length. 
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When the vein is torn during stripping, the caudal end typically 
remains in place at the lower incision. In this case, if a trailing heavy silk 
suture has been affixed to the stripper, a second inversion technique could 
be performed in the opposite direction 
Adjunctive Considerations for Stripping Procedures 
Saphenous vein stripping is commonly perceived as a painful and 
morbid procedure by patients and referring physicians alike. The memory 
of large incisions, extensive bruising, significant pain, and prolonged 
disability from antiquated techniques is a major concern of patients and 
referring physicians. These undesirable effects can be significantly 
ameliorated by using relatively simple adjunctive techniques. 
Ultrasound Guidance 
DUS used to preoperatively mark the saphenofemoral or 
saphenopopliteal junction. It  allows precise placement of the skin 
incision and permits very small incisions with limited subcutaneous 
dissection. 
Tumescent Anesthesia 
The GSV in thigh lies within a fascial envelope, which allows 
modest infusion of tumescent anesthesia (200 to 500 mL) to fully 
surround the saphenous vein. We use a combination of 40 mL of 1% 
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lidocaine with epinephrine, 10 mL of sodium bicarbonate, and 450 mL of 
normal saline. This technique provides excellent anesthesia and allows 
vein stripping to be performed under straight local anesthesia in an office 
setting. 
Minimization of Accumulation of Blood in the Stripping Tunnel 
If blood is left in place in the stripping tunnel, a firm palpable cord 
sometimes called pseudothrombophlebitis results. This will eventually 
reabsorb but contributes to the significant early discomfort. 
In addition to the use of tumescent anesthesia, we recommend that 
stripping be performed as the last step of the procedure if concurrent 
tributary varices or perforator disease is to be addressed at the same 
setting. In this way the leg can be immediately wrapped in a compressive 
dressing and elevated after the vein stripping is performed. 
Leg Elevation before and during Stripping 
Elevation of the leg reduces the venous bleeding and ecchymosis 
associated with stripping. The leg should be elevated before the actual 
stripping procedure is performed. Postoperatively, the patient should 
ambulate as soon as possible. 
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SURGERY ON THE SMALL SAPHENOUS VEIN AND VEINS OF 
THE POPLITEAL FOSSA 
SSV disease is often neglected by surgeons and, when addressed, is 
frequently incompletely treated. This problem may be explained by the 
following factors: 
(1)  the paucity of studies emphasizing a significant contributory 
role of SSV 
(2)  the lower proportion of limbs with SSV reflux than with 
GSV incompetence 
(3)  technical considerations, such as the need to reposition the 
patient if both GSV surgery and SSV surgery are being 
performed in the same treatment session 
(4)  the intimate and variable neurovascular relationships of the 
SSV, which can present significant potential for morbidity. 
Although nearly 90% of surgeons carried out preoperative duplex 
imaging, only 50% added preoperative skin marking of the 
saphenopopliteal junction. In an effort to avoid damage to neurovascular 
structures and also DVT, few surgeons (10%) exposed the popliteal vein 
during this procedure, which would make treatment of gastrocnemius or 
popliteal area veins difficult. 
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An understanding of the relationship of the SSV to other veins of 
the popliteal fossa-the gastrocnemius veins, the intersaphenous vein, and 
popliteal area veins-is important to achieve optimal results with SSV 
surgery. If these veins are ignored, they can be a factor in persistence of 
reflux. These veins can be attacked directly only by open surgery and not 
by EVA or forms of sclerotherapy, particularly when these veins directly 
enter the popliteal vein. 
Operative Technique 
After induction of general, regional, or local anesthesia, patients 
are positioned prone with care taken to pad bony areas. To provide laxity 
of neurovascular structures in the popliteal fossa, the affected limb is 
slightly flexed at knee with a rolled towel placed under the ankle. 
Preoperative marking by DUS allows a small skin incision to be 
made just distal to previously marked saphenopopliteal junction. The 
length of the transverse incision is dictated by the thickness of the 
subcutaneous tissue. 
The fascia is opened along the line of the skin incision and the SSV 
identified. The SSV is traced distally to its position between the fascia 
and calf muscles. Because of the effects of sustained venous 
hypertension, the SSV can resemble an artery (popliteal), so continuous 
wave Doppler scrutiny of the vessel may be used on occasion to provide 
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the surgeon with assurance that the structure is indeed venous in nature. 
The SSV is then divided between two right-angle clamps. 
Care should be taken to dissect in the perivenous plane, and any 
nerve structure-usually sural-is carefully dissected from the SSV. Gentle 
retraction is used to avoid injury to the tibial nerve and to visualize the 
saphenopopliteal junction. However, if DUS identifies reflux in the 
gastrocnemius or popliteal area veins, the exposure is extended and the 
target veins ligated. The stump of the SSV is ligated with a 3-0 
monofilament transfixion suture. If present, the common trunk of the SSV 
with either the gastrocnemius or intersaphenous veins is ligated 
proximally just above the popliteal vein, and the two veins in turn are also 
ligated. 
The SSV is ligated distally with 3-0 monofilament suture. The 
popliteal wound is then irrigated and closed in layers with particular 
attention paid to approximating the fascia to avoid unsightly hernias. The 
short skin incision is approximated with running 5-0 subcuticular suture. 
Particular attention is paid to ligate any incompetent gastrocnemius 
perforating veins that connect with the SSV branches. 
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Excision of Local Varicosities (Ambulatory Phlebectomy) 
By  removing  the  source  of  axial  reflux,  flush  L&S  of  the  GSV,  
SSV, or both are responsible for the greatest hemodynamic benefit in 
most vein operations. However, the remaining superficial varicosities, if 
left uninterrupted, will drain via alternative pathways and may remain 
both symptomatic and cosmetically displeasing to patients. In the past, 
these varices were dealt with by making several large incisions, and 
dramatic transverse scars were left in many cases. Refinements in 
technique have resulted in improved cosmetic results with effective 
elimination of tributary varices through small (1 to 3 mm) stab incisions. 
Effective use of these minimally invasive techniques requires planning, 
experience, and patience. It is common for procedures to require in 
excess of 20 phlebectomies, which can be time-consuming. Preoperative 
marking is very important in ambulatory phlebectomy. These target veins 
are often difficult to see when the patient is reclining. 
Phlebectomy is best performed on a horizontal plane, and because 
many patients are treated under a local anesthetic, it is often possible to 
have them rotate their extremity during the procedure to maximize 
exposure.  
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ENDOVENOUS THERMAL ABLATION 
The evolution of minimally invasive techniques for the treatment 
of GSV reflux has culminated in the development of EVA. Under 
ultrasound guidance the saphenous vein is percutaneously accessed and 
the catheter advanced cephalad toward the saphenofemoral junction. 
Tumescent anesthesia and thermal energy are used in concert to provide 
an effective means of eliminating GSV reflux. 
RESULTS 
For  a  century  L&S has  been  the  “gold  standard”  for  treatment  of  
GSV incompetence and tributary avulsion for residual varicose veins. The 
preponderance of data advocating a surgical approach to varicose veins is 
derived from clinical reports of L&S. The role of L&S has diminished 
greatly  with the advent of EVA by either laser or radiofrequency 
methods, and sclerotherapy has replaced tributary avulsion in many cases. 
Results of Surgery on the GSV versus Conservative Treatment 
The ESCHAR (Effect of Surgery and Compression on Healing 
And Recurrence) trial was the first large prospective randomized trial to 
address this fundamental question. Patients with severe sequelae of CVI 
(C5 to C6) and superficial or mixed deep and superficial venous 
insufficiency were randomized to medical therapy (elevation, 
compression,  and  exercise)  either  with  or  without  surgical  treatment  of  
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superficial venous reflux. Although no difference was found in rates of 
healing, there was a dramatic reduction in ulcer recurrence (12% versus 
28% at 12 months; P < .001). This study has been criticized for using 
class II rather than class III stockings. However, it should be noted that 
both groups received the same compression garments and that in practice 
compliance drops off as the degree of compression is increased.  
Michaels and colleagues recently carried out an RCT that 
examined the impact of superficial venous surgery on quality of life in 
246 patients with uncomplicated varicose veins who were randomized to 
compression and lifestyle changes versus surgery with L&S of refluxing 
segments and multiple phlebectomies.  
The surgical group showed significant improvement in quality-
adjusted life years over the group treated by compression. Quality-
adjusted life years as assessed by SF-36 were improved by 0.083 over the 
medically treated group and by 0.13 as assessed by the EQ-5D. In 
addition, the surgical group demonstrated significant anatomic and 
symptomatic relief. These large RCTs provide a grade A recommendation 
for surgery in addition to conservative treatment in patients with varicose 
veins caused by GSV reflux. 
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Comparison of Results of Endovenous Ablation versus Ligation and 
Stripping of the Great Saphenous Vein 
Our review of the literature identified seven RCTs in which EVA 
was compared with L&S. Three of these studies compared laser treatment 
with L&S, whereas two compared radiofrequency ablation with L&S. 
These later two studies published subsequent follow-up data as two 
additional papers. The studies were of modest size, with 28 to 137 limbs 
being treated. Many of the RCTs were lacking some elements of proper 
study design: a prior calculation of sample size, comparability of baseline 
characteristics between groups, and intention-to-treat analysis. 
Desirable outcome measures such as quality of life were used in six 
of the seven studies, whereas five of the seven RCTs provided a disease-
specific evaluative score so that preoperative values could be compared 
with postoperative values. Overall, there was an early postoperative 
advantage of EVA in quality of life, but by 1 month the disease-specific 
scores were comparable. “Soft” outcome measures such as return to 
normal activities or work and less postoperative pain also favored EVA. 
Rasmussen, Perýlý, Darwood, and their colleagues found no 
difference between L&S and EVA in disease-specific scores by 1 month 
postoperatively. Four RCTs provided a postoperative quality of life 
assessment, but these measures were usually conducted late at an average 
of 1 month after the procedure. Two RCTs (Rasmussen and associates 
and Kalteis and colleagues showed no difference in quality of life 
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measures, whereas two demonstrated an advantage for EVA (Rautio and 
associates and Lurie and colleagues). Morbidity is putatively less with 
EVA because the vein is ablated in place. L&S, however, involves 
stripping the vein with avulsion of branches and some tract bleeding, 
which can be mitigated but will never be completely eliminated. 
Certainly, if thrombophlebitis develops in the ablated GSV, the pain can 
be as severe as that with stripping. The use of postoperative analgesics is 
usual with L&S, in contrast to EVA. 
We have observed that local tumescent anesthesia results in 
reduced pain and bruising with vein stripping and phlebectomy, as well as 
with  EVA.  Rasmussen  and  colleagues  compared  L&S  and  EVA  in  a  
randomized trial in which tumescent anesthesia was used in all patients. 
In this report, 121 patients (137 limbs) were randomized to high L&S 
with local anesthesia or endovenous laser treatment. Both groups had 
varicosities removed through miniphlebectomies and received perivenous 
tumescent solution and intravenous fentanyl. L&S was performed by the 
perforate-invaginate stripping technique. These treatments were found to 
be equally effective in eliminating GSV reflux, with no difference in time 
to resume normal activity or return to work. There was more pain and 
bruising in the L&S group but no change in pain medication. No 
difference was observed in the Venous Clinical Severity Score or in the 
Aberdeen score between the two groups at any time point. The bodily 
pain score component of the SF-36 was higher after L&S than after EVA 
12 days postoperatively. 
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Indications for Ligation and Stripping of the Great Saphenous Vein 
in the Current Climate Favoring Endovenous Thermal Ablation 
1. Superficial saphenous tributary. The most common indication for 
L&S of GSV is to treat a superficial tributary of the saphenous vein that 
is closely adherent to the skin. This vein can be an “extrafascial” 
continuation of the main GSV as a superficial branch or, alternatively, a 
separate anterior accessory saphenous vein or a truly duplicated GSV. 
The inability to create at least a 1-cm buffer zone between skin and vein 
with tumescent anesthesia during thermal ablation increases the risk for 
skin burns and is a clear contraindication to EVA. These patients more 
frequently undergo a stab phlebectomy of this venous segment rather than 
the classic L&S. 
2. GSV dilatation or aneurysmal venous segments. Dilatation of the 
proximal GSV to greater than 2.5 to 3 cm or large aneurysmal venous 
segments along the course of the GSV are also an indication for L&S. 
Despite external compression, copious tumescent solution, and the use of 
high thermal energy by either laser or second-generation radiofrequency 
ablation, the proximal GSV may be difficult to ablate effectively and may 
be more prone to thrombotic complications. 
3. Chronic thrombophlebitis. Synechial formation within the GSV as 
a sequela of superficial thrombophlebitis may prevent advancement of the 
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radiofrequency ablation catheter or laser sheath. This may occur even if a 
guide  wire  crosses  the  diseased  segment.  In  this  situation  it  is  often  
possible to perform high L&S with the flexible Codman stripper or the 
relatively stiff wire PIN strippers. If this also fails, simple ligation plus 
segmental excision is performed. In addition, if the vein wall is noted to 
be markedly thickened on DUS, it will not constrict appropriately in 
response to thermal ablation and would be more effectively treated with 
L&S. 
4. Excessive tortuosity (same considerations as in No. 3). 
5. Acute superficial thrombosis. Acute superficial vein thrombosis 
with extension to saphenofemoral junction remains an indication for 
anticoagulation, GSV ligation, or both to prevent extension to the femoral 
vein. EVA is clearly contraindicated in any vein with acute thrombus. 
In summary, L&S has decreased in popularity as a technique for 
treating GSV reflux because of the less invasive nature of EVA. 
However,  for  the  previously  stated  reasons,  L&S of  the  GSV remains  a  
relevant procedure with a definite place in a modern venous practice. 
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ENDOVENOUS TREATMENT 
BACKGROUND 
The standard treatment of varicose veins for many years has been 
surgical L & S of the affected vein. Although outcomes have improved in 
recent years because of improved understanding of lower extremity 
venous anatomy, the failure rate with this approach is frequently reported 
to be between 20% and 30%. In addition, surgical ligation and stripping 
are invasive, usually requiring general anesthesia and several weeks’ 
recovery before return to normal activities.  
In response to need for a less invasive approach, numerous 
endovenous treatments have emerged over the past several years. 
Endovenous treatment as it relates to varicose veins can best be defined 
as a minimally invasive, catheter-based technique that inflicts endothelial 
damage to a target vessel to produce thrombosis, fibrosis, and complete 
eradication of the vessel. The most notable endovenous advancements 
are: 
Radiofrequency ablation (RFA) and endovenous laser ablation 
(ELA). These methods have demonstrated clinical superiority to stripping 
and surgical ligation, as well as significantly less postoperative pain and 
recovery time. 
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TREATMENT SELECTION 
Accepted endovenous treatment modalities include endovenous 
thermal ablation, sclerotherapy, cutaneous lasers, and IPL devices. 
Although each treatment modality has its specific advantages and 
indications, there is significant overlap. When considering a treatment 
algorithm, the clinician must be selective and base decisions on the needs 
of each individual patient. The primary goal in treating venous 
insufficiency is to first treat the highest point of reflux. Additional goals 
include eradication of all diseased varicosities, minimization of 
complications, relief of symptoms, and attainment of satisfactory 
cosmetic results.  
Endovenous Options for the Treatment of Reflux 
 
Type of Treatment Vessels Treated 
Radiofrequency ablation 
Saphenous vein trunks 
Saphenous vein tributaries 
Anterior thigh circumflex 
Intersaphenous vein 
Perforators 
Endovenous laser ablation Saphenous vein trunks 
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Type of Treatment Vessels Treated 
Saphenous vein tributaries 
Anterior thigh circumflex 
Intersaphenous vein 
Perforators 
Ultrasound-guided 
sclerotherapy 
Saphenous vein trunks 
Saphenous vein tributaries 
Anterior thigh circumflex 
Intersaphenous vein 
Perforators 
Varicose veins not connected to 
saphenous vein trunks 
Visual or surface sclerotherapy 
Varicose veins 
Reticular veins 
Telangiectases 
Cutaneous lasers and intense 
pulse light 
Reticular veins less than 2 mm 
Telangiectases 
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RADIOFREQUENCY ABLATION 
RFA is an emerging minimally invasive technology that provides 
efficacious treatment of venous reflux with minimal discomfort and 
downtime for patients. One of the primary advantages of RFA is that the 
current procedure can be performed in an outpatient office setting under 
local tumescent anesthesia. As discussed earlier, the latest RFA technique 
includes several improvements over the original technology and features 
a “segmental ablation” method using the ClosureFAST system that is 
designed for treating both the GSV and SSV. 
The Closure FAST catheter is constructed with a 7-cm bipolar 
electrode affixed to its distal end. The mechanism is such that the 
electrode must make direct contact with the vein wall to deliver 
radiofrequency energy. Contact with wall results in destruction of the 
endothelium, occlusion by contraction of vein wall collagen, and 
thrombus formation. Eventually, fibrosis occurs within the vein, as well 
as the formation of new collagen matrix, which further constricts the vein 
lumen and successfully occludes the vein. 
RFA is indicated for superficial vein reflux of the lower extremity; 
contraindications include superficial venous thrombosis, deep venous 
thrombosis, aneurysm, and an ankle-brachial index of less than 0.9. 
Though having a pacemaker is not listed as a contraindication, there is 
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concern regarding  use of RFA in patients with pacemaker. The patient's 
cardiologist should be consulted before the procedure. 
Preoperative Planning 
Patient should be well hydrated to achieve maximum distention of 
the  leg  veins.  In  preparation  for   procedure,  DUS  is  performed  to  mark  
the skin overlying the target treatment vein. A surgical marking pen is 
used to avoid accidental tattooing of the skin. Under DUS, the highest 
point of reflux is marked and serves as a guide during the RFA procedure. 
When performing ultrasound it is advisable to heat the ultrasound gel 
before placing it on the patient's leg because cold gel could cause 
venospasm. Similarly, the patient should be kept warm and comfortable 
in the procedure room to further avoid venospasm. Mild sedation such as 
alprazolam, diazepam, or lorazepam may be prescribed for patients who 
exhibit anxiety. 
Radiofrequency Ablation Procedure 
An access site that will allow successful treatment of all possible 
diseased segments of the target vein is identified ultrasonically. For 
ablation of the GSV, access is routinely initiated at or just below popliteal 
area. With the patient in the reverse Trendelenburg position, lidocaine is 
administered at the selected site and a percutaneous technique with a 21-
gauge needle is used to gain access under ultrasound guidance. A small 
cut-down may be used but is not the preferred technique because of 
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cosmetic concerns. A 0.018-inch guide wire is inserted into the GSV and 
the needle is removed. 
Next, a 7 Fr ý 7-cm or 11-cm sheath is advanced over the wire, the 
0.018-inch  wire  is  removed,  and  the  7  Fr  ClosureFAST  catheter  is  
inserted. The catheter is advanced to the predetermined point at which 
treatment will begin. If the catheter does not advance easily, a 0.025-inch 
guide wire may be back-loaded into the device to assist in passage. When 
treating  GSV,  optimal  positioning  of  the  catheter  tip  is  just  below  the  
ostium  of  the  superficial  epigastric  vein  or  2  cm  below  the  SFJ,  
whichever is more peripheral.  
After correct placement of the catheter tip is confirmed by 
ultrasound, perivenous tumescent anesthesia is administered under 
ultrasound guidance along the entire target treatment length to create a 
fluid layer around the GSV. Proper administration of tumescent 
anesthesia is a critical component of the procedure because it not only 
serves as an anesthetic but also compresses the vein around the catheter 
and protects the surrounding tissue from heat damage. 
The type of needle used is based on user preference; popular 
choices include a 25-gauge hypodermic needle or a 22-gauge spinal 
needle. The needle is connected to a 20-mL syringe, 20-mL refillable 
syringe, or specialized tubing that is used in conjunction with an infusion 
pump. 
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In addition to tumescent anesthesia, a technique that is crucial for 
success of the procedure is apposite compression. In instructions for use 
of  the  ClosureFAST  system,  VNUS  recommends  that  compression  be  
applied with the ultrasound transducer positioned longitudinally over the 
heating  element,  as  well  as  with  two  fingers  distal  to  the  transducer.  
When prepared to begin, the generator is turned on and the unit is ready 
to use. With the segmental ablation technique of the ClosureFAST 
system, each 7-cm segment is treated independently for a 20-second 
treatment interval. 
Radiofrequency energy is delivered by pressing the button located 
on the handle of the catheter; once a 20-second interval is complete, 
delivery of energy will automatically stop. The initial treatment segment 
2  cm  inferior  to  the  SFJ  requires  two  20-second  cycles  to  ensure  
successful ablation. Additionally, aneurysmal or large-diameter segments 
may be treated twice at the user's discretion. For each 20-second cycle, 
the temperature must reach 120ý C within 5 seconds after the initiation of 
delivery of the energy; if this temperature is not achieved within the 
stated time frame, the segment must undergo another 20-second treatment 
cycle. The RFG Plus generator monitors all parameters during the 
treatment cycle and alerts the user if the parameters are not successfully 
met. A segment should not undergo more than three treatment cycles. 
On completion of each 7-cm segment, the catheter is repositioned 
to the contiguous segment by using the 6.5-cm stepped markers on the 
49 
 
catheter shaft. The 6.5-cm spacing allows 0.5-cm overlap of each 
segment to ensure that no untreated areas are left between segments. This 
process is repeated until the desired vessel length is treated and can last 
from 1 to 5 minutes, depending on the length of the vessel and the 
number of repeated segments. When positioning the catheter for the final 
segment, the user should avoid pulling the heating element into the sheath 
because it may melt the sheath. After treatment, duplex ultrasound is used 
to assess the treated vein for absence of reflux and evidence of occlusion. 
Discharge and Follow-up 
Postoperative compression with a 30 to 40 mm Hg graduated 
stocking is recommended for at least 1 week. Patients are instructed to 
ambulate after the procedure before leaving the facility. A DUS follow-
up examination is advised at 72 hours after the procedure to inspect for 
extension  of  thrombus  into  the  deep  system  and  to  assess  the  treated  
veins. Further follow-up evaluations are performed according to 
physician preference; experts advocate examination at 3 months, 6 
months, and 1 year after ablation. 
Complications 
Potential complications may include vessel perforation, 
thrombosis, pulmonary embolism, phlebitis, infection, nerve injury, and 
skin burns or discoloration.  
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ENDOVENOUS LASER ABLATION 
ELA has many similarities to RFA, with the primary differences 
related to catheter and mechanism used to ablate the vein. ELA uses a 
600-ým bare-tipped or jacket-tipped fiber to deliver laser energy to a 
target area and form steam bubbles within vein lumen. The steam bubbles 
generate heat within the lumen of the target vessel, which destroys the 
endothelial lining of the vessel. This causes an inflammatory reaction 
resulting in a thrombotic occlusion that effectively closes off the vein and 
eventually leads to fibrosis. 
Laser Wavelengths 
Numerous different endovenous laser wavelengths have been used 
to generate endothelial destruction of varicose veins, including 810, 940, 
980, 1064, 1319, 1320, and 1470 nm. Since the advent of endovenous 
lasers, there have been several theories centered around the efficacy of 
wavelengths absorbed by water and hemoglobin. Research on the optical 
properties of blood has shown that different wavelengths have variable 
absorption characteristics: 
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Endothermal Ablation Devices 
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Generator type 810-nm diode laser 
810-nm diode 
laser 
940-nm 
Nd : YAG laser 
980-nm 
diode laser 
1319-nm 
Nd : YAG 
laser 
1320 nm 1470 nm Radiofrequency original 
Radiofrequency 
segmental 
Output 15 or 30 W 15 W 120 W 15 W 15 W 10 W 15 W 85ý 120ý 
Delivery device Bare-tipped 600-ým fiber 
Jacket-tipped  
600-ým fiber 
Bare-tipped 600-
ým fiber with 
Laser Fiber 
Protection 
System (LPS) 
Jacket-
tipped 600-
ým fiber 
Bare-tipped 
600-ým fiber 
Bare-tipped 
600-ým 
fiber 
Bare-tipped 600-
ým fiber 
Multiple 
thermocouple 
electrode probes 
Single 
thermocouple 
electrode 
Mechanism of 
energy delivery 
Emitting face of 
fiber makes 
contact with and 
destroys 
endothelium 
Formation of 
steam bubbles 
generates 
intraluminal heat 
and destroys 
endothelium 
Formation of 
steam bubbles 
generates 
intraluminal heat 
and destroys 
endothelium 
Formation 
of steam 
bubbles 
generates 
intraluminal 
heat and 
destroys 
endothelium 
Endothelial 
cells absorb 
light and 
generate heat 
that collapses 
vein walls 
Coagulates 
endothelium 
Intracellular 
water in 
endothelium and 
blood absorbs 
laser energy and 
occludes vessel 
Probes make 
contact with 
endothelium and 
deliver energy 
that contracts vein 
wall collagen 
Singular 
electrode makes 
contact with 
endothelium 
and delivers 
energy that 
contracts vein 
wall collagen 
Catheter/sheath 
size 4 Fr 5 Fr None 4 Fr None None None 6 or 8 Fr 7 Fr 
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Catheter/sheath 
markings Every centimeter Every centimeter None 
Every 
centimeter; 
1-mm 
markings on 
distal tip 
None None None Every centimeter Every 6.5 cm 
Over-the-wire 
system Yes (0.035 in) Yes (0.035 in) 
Sheath 
dependent 
Yes (0.035 
in) 
Sheath 
dependent 
Sheath 
dependent 
Sheath 
dependent Yes (0.025 in) Yes (0.025 in) 
Access system Micro-access set Micro-access set None Micro-access set None None None 
18-gauge needle 
or micro-access 
set 
18-gauge needle 
or micro-access 
set 
Aiming beam Adjustable red beam 
Adjustable red 
beam 
Adjustable red 
beam 
Adjustable 
red beam 
Adjustable red 
beam 
Adjustable 
red beam 
Adjustable red 
beam None None 
Manufacturer-
recommended 
pullback 
1 cm every 3-5 
seconds 50-70 J/cm 
1 cm every 3-5 
seconds 50-80 J/cm Unknown 
Automated 
fiber 
pullback 
device at 
1 mm/sec 
Unknown 
1-2 cm/min  
(15-20 minutes 
total) 
20 seconds per 
7-cm segment 
(3-5 minutes 
total) 
Compression 
during 
procedure 
No No No No No No No Yes Yes 
Maximum vein 
size None None None None None None None Unknown Unknown 
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• The 810-nm wavelength is specific for hemoglobin absorption. 
 
• The 940-nm wavelength provides a balanced ratio between the light 
irradiated into tissue and its absorption by hemoglobin and 
water. 
 
• The 980-nm wavelength is specific for hemoglobin and water. 
 
• The 1319/1320-nm wavelength is specific for water absorption, 
and it targets collagen in the vein wall. 
 
• The 1470-nm wavelength features an absorption coefficient in water 
that is 40 times greater than that of the 810- and 980-nm 
wavelengths. 
Preoperative Planning 
Preoperative planning for ELA is virtually identical to that for 
RFA. An indelible marking pen is used to mark incompetent sources of 
venous reflux under duplex ultrasound guidance. Steps should be taken to 
avoid venospasm, such as keeping the room warm and the patient warm 
and comfortable. A mild sedative similar to alprazolam, diazepam, or 
lorazepam may be prescribed for the patient before the day of the 
procedure. The sedative can be brought with the patient in the event that 
it is needed. 
Endovenous Laser Ablation Procedure 
As with RFA, when treating the GSV, the target access site is at or 
slightly below popliteal area. Experienced physicians may attempt to gain 
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access lower on the leg if the vein exhibits reflux distally; however, this 
adds risk to the procedure because the saphenous nerve lies adjacent to 
GSV within the saphenous compartment in the lower part of the leg. 
Ablating the GSV in the lower leg region may increase the risk for 
paresthesia as a result of the proximity of the saphenous nerve. A micro-
access set (21-gauge needle, 0.018-inch wire, and microsheath) is used to 
initiate access. An 18-gauge needle or a cut-down is also effective but not 
preferred because of the increased risk for trauma to the vessel or 
venospasm. Once the microsheath is inserted into the GSV, the distance 
from the access site to SFJ is measured. The inner dilator of the 
microsheath is removed and a 0.035-inch guide wire is advanced through 
the microsheath to SFJ under ultrasound guidance. The microsheath is 
removed and a long sheath is selected on the basis of measured distance 
from the SFJ to the access site. The sheath selected, most commonly 
45 cm in length, is back-loaded over the guide wire to a point just distal 
to the superficial epigastric vein. Once in place, the inner dilator and 
guide wire are removed and a 600-ým bare-tipped or jacket-tipped fiber is 
advanced into the sheath. The fiber is then connected to the generator and 
the aiming beam turned on to help visualize the fiber tip under the skin. 
While the fiber is held in place, the sheath is withdrawn to the locking 
mechanism of the fiber and locked in place, with the tip of the fiber 
exposed approximately 2 cm past the end of the sheath. Positioning is 
reconfirmed with ultrasound, and preparation is made to administer 
tumescent anesthesia. Similar to RFA, tumescent anesthesia is injected 
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perivenously. with a 22- or 25-gauge hypodermic needle. A hand-
delivery method, a syringe refill system, or a pump may be used for 
administration. Hand delivery is the best technique for learning how to 
perform tumescent anesthesia under ultrasound guidance. I prefer to use a 
refillable syringe or tumescent pump because it decreases the time needed 
for delivery of tumescent anesthesia and reduces the number of needle 
punctures. The volume of fluid delivered is dictated by the distance 
created between the skin and the vein; the target diameter of fluid around 
the vein is 10 mm, which can be ensured with ultrasound. Positioning of 
the laser fiber tip is then reconfirmed before commencing with the 
procedure. 
Procedure Variations 
As the endovenous laser procedure has progressed and improved 
over the past few years, several variations in method have developed. A 
majority of the variations are related to pullback time and the amount of 
energy delivered. After the continuous mode replaced the pulsed mode as 
the preferred mechanism, the initial pullback rates for the laser fiber were 
3 mm/sec (18 cm/min). Another popular protocol was a pullback rate of 
1  cm  every  3  to  5  seconds,  which  equates  to  a  relatively  variable  12  to  
20 cm/min. Accurately gauging the pullback rate was challenging 
because the first sheaths did not contain any type of dashes or marks. 
Pullback speed was estimated by an assistant calling out increments of 
time so that the physician could use best judgment.  
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Many experts now focus on total energy delivered and gauge 
pullback during ELA procedures according to joules delivered per 
centimeter. This has been termed linear endovenous energy density. 
Currently, 50 to 80 J/cm is the average treatment energy most often used 
for ELA procedures. Continuous pullback is used while watching the 
real-time energy readout on the generator and gauging speed with 1-cm 
marks on the sheath. This method has proved to be more consistent than 
using time to gauge pullback because the same amount of energy is 
delivered in each case. 
Once tip positioning is confirmed, the laser is switched from 
standby to ready mode and the foot pedal is depressed to deliver energy. 
While using the preferred method to gauge pullback, the laser fiber and 
sheath are drawn through the vessel simultaneously in a continuous 
fashion. Treatment is stopped by removing one's foot from pedal when 
the tip of the laser fiber is approximately 1 to 3 cm above the entry site to 
prevent skin burns or trauma to the entry site. Closure of the vein is 
visualized with duplex ultrasound, followed by removal of the fiber and 
sheath. 
Discharge and Follow-up 
The entry site is covered with Steri-Strip cut into thirds and dressed 
with a sterile gauze pad. Patients are fitted with a 30 to 40 mm Hg 
graduated stocking and instructed to wear the stocking continuously for 
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the first 24 hours. After this initial period the stockings are worn during 
nonsleeping hours for a period of at least 1 week. Patients ambulate 
immediately to promote the vessel occlusion process and decrease the 
incidence of DVT. NSAIDs may be taken daily as needed for the first 7 
to 10 days after the procedure. DUS follow-up examination is performed 
according to surgeon’s preference; however, evaluation within 72 hours 
to 1 week after the procedure is recommended for assessing the treated 
veins and inspecting for DVT. 
Complications 
Potential complications may include but are not limited to vessel 
perforation, thrombosis, pulmonary embolism, phlebitis, hematoma, 
infection, skin pigmentation, neovascularization, paresthesia, 
complications from tumescent anesthesia, irradiation of nontarget tissue, 
hemorrhage, necrosis, skin burns, and pain.  
SCLEROTHERAPY 
Sclerotherapy can be used to treat a myriad of vein types and sizes, 
although it is most commonly used to treat smaller vessels such as the 
reticular veins and telangiectases. Sclerotherapy is best defined as the 
introduction of a chemical into the lumen of a vein to induce endothelial 
damage that results in thrombosis and eventually fibrosis. Considered the 
most versatile treatment option for venous ablation, sclerotherapy can be 
used to treat a large range of vein sizes from telangiectases to large 
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varicose veins. With the advent of the radiofrequency and endovenous 
laser procedures, the primary intent of sclerotherapy is to effectively 
eliminate the target vein after the highest point of reflux is treated with 
one of these new modalities. 
Sclerotherapy entails several different methods to deliver a 
sclerosing agent, depending on the diameter of the target vein. For 
smaller veins such as telangiectases, venulectases, and small reticular 
veins, liquid sclerotherapy is used to deliver injections directly into the 
target vein. Larger reticular veins and other varicose veins may also be 
treated by liquid sclerotherapy with a higher concentration of sclerosing 
agent or by foam sclerotherapy. Foam sclerotherapy involves the addition 
of air to a detergent sclerosing agent by means of agitation to produce a 
foam-like consistency, which allows enhanced contact with vein wall on 
injection. Because the sclerosing agent must make contact with vein wall 
to cause endothelial damage, the primary limitation of sclerotherapy is 
vein diameter. Effective interaction with vein wall may be encumbered 
by blood flow within larger veins dissipating the agent. An innovative 
method using a catheter to deliver sclerosants has also emerged as an 
option for larger veins. There are several indications and 
contraindications to be cognizant of before performing sclerotherapy. 
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Sclerosing Agents 
Sclerosing agents are most commonly grouped into categories 
based on their mechanism of action for producing endothelial damage. 
Categories of currently available solutions include osmotics, alcohol, 
and detergents. Ideal sclerosing agents can effectively damage the 
endothelium, exhibit a low incidence of adverse events, and are painless 
to inject. Relative contraindications to sclerotherapy include but may not 
be limited to asthma, late complications of diabetes, hypercoagulable 
state, leg edema, advanced peripheral arterial occlusive disease, and 
chronic renal insufficiency. Absolute contraindications are a known 
allergy to the sclerosant, acute cellulitis, acute respiratory or skin disease, 
severe systemic disease, phlebitis migrans, acute superficial 
thrombophlebitis, pregnancy, hyperthyroidism, and bedridden status. 
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Hypertonic 
saline Multiple Osmotic 
Off-label 
use ++ 
Low risk of 
allergic reaction, 
wide availability, 
rapid response 
Off-label, painful to 
inject, 
hyperpigmentation, 
necrosis, rapid dilution, 
not recommended for 
facial veins 
Sclerodex 
(hypertonic 
saline and 
dextrose) 
Omega 
Laboratories
, Canada 
Osmotic Not approved ++ 
Low risk of 
allergic reaction, 
low risk of 
necrosis, high 
viscosity 
Not FDA approved, 
stings when injected, 
hyperpigmentation 
Chromex (72% 
chromated 
glycerin) 
Omega 
Laboratories
, Canada 
Alcohol Not approved + 
Low incidence of 
hyperpigmentati
on, necrosis, and 
allergic reaction 
Not FDA approved, 
weak sclerosing agent, 
highly viscous and 
painful to inject, may 
cause hematuria at high 
doses 
Nonchromated 
glycerin 
Compounde
d at 
pharmacy 
Alcohol Off-label use + 
Low incidence of 
hyperpigmentati
on, necrosis, and 
allergic reaction 
Weak sclerosing agent, 
typically only used for 
telangiectases 
Scleromate 
(sodium 
morrhuate) 
Glenwood, 
LLC, USA Detergent Approved +++ FDA approved 
High incidence of skin 
necrosis and 
anaphylaxis 
Sotradecol 
(sodium 
tetradecyl 
sulfate) 
Bioniche 
Pharma, 
USA 
(distributed 
by 
AngioDyna
mics, Inc.) 
Detergent Approved +++++ 
FDA approved, 
low risk of 
allergic reaction, 
potent sclerosant 
Potential necrosis with 
extravasation, matting 
of telangiectases 
Aethoxysklerol 
(polidocanol) 
Kreussler 
Pharma, 
Germany 
Detergent Not approved +++ 
Very low risk of 
allergic reaction, 
painless to inject 
Not FDA approved, 
associated with matting 
of telangiectases 
 
Preoperative Planning 
Digital photographs of the target veins should be obtained to 
document their appearance before sclerotherapy is performed. Larger 
61 
 
target veins such as varicose veins should be traced with a surgical 
marker with the patient standing because they may be difficult or 
impossible to identify during supine. Preoperative marking is typically 
not required for smaller veins such as telangiectases and reticular veins. 
When sclerotherapy is combined with endothermal ablation of the 
saphenous veins, sclerotherapy below the knee should be performed 
second. If a staged approach is used, the GSV or SSV should be treated 
first, with sclerotherapy following several weeks later. This method 
allows the existing truncal varicosities to shrink or disappear before 
further procedures. Several sclerotherapy treatments may be necessary to 
eliminate the veins, depending on the number and severity of diseased 
veins. It is important to establish the expectation that several sessions 
could be required and explain the sclerotherapy process to patients. 
Sclerotherapy Procedure 
After preoperative preparation, the sclerosing agent is diluted with 
0.9% saline according to the size of the vein. Recommendations are the 
following dilutions in concentration for STS: 0.125% to 0.25% for 
telangiectases, 0.25% to 0.5% for reticular veins, and 0.5% to 3.0% for 
varicose vein.  
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Indications for Sclerotherapy and Recommended Concentrations of 
Sodium Tetradecyl Sulfate (STS) 
Indications Recommended STS Concentration 
Varicose veins <8 mm 0.5%-3.0% 
Reticular veins 2-4 mm 0.25%-0.5% 
Telangiectasias 0.1-2.0 mm 0.125%-0.25% 
Recurrent varicosities 0.5%-3.0% 
Failed segments of endothermal 
ablation 0.5%-3.0% 
Unsightly veins of the hands and feet 0.25%-0.5% 
Congenital malformations 0.125%-0.25% 
Vascular malformations 0.125%-0.25% 
Facial telangiectases 0.125%-0.25% 
 
Liquid Sclerotherapy 
After dilution of agent, multiple syringes are filled and assembled 
with 30-gauge needles for performing liquid sclerotherapy. For best 
results, veins should be treated from the largest diameter to the smallest 
and in a proximal-to-distal direction. When injecting at most proximal 
source, the sclerosing agent flows away from the point of injection.  
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Ultrasound-Guided Foam Sclerotherapy 
Tessari method has been found by many to be a superior technique 
in which significant coalescence does not begin until after the first 1 to 2 
minutes. When diluting an agent for use with the foam method, the final 
concentration is dependent on the air-to-liquid ratio. For Tessari method, 
a ratio of one part liquid to four or five parts air has shown excellent 
stability and efficacy. When using the dilution guidelines given in this 
section, the smaller value of each range should be used when applying the 
foam method. 
Depending  on  the  size  and  depth  of  the  target  veins,  DUS can  be  
helpful in guiding the injection of foamed sclerosants. If choosing to use 
ultrasound-guided sclerotherapy, incompetent target vein segments 
should be marked before the procedure. After mapping the treatment area, 
access to the first vein to be treated is achieved under ultrasound 
guidance. Access is confirmed by return of blood, and the needle is taped 
to the patient's  leg.  The sclerosing agent  is  prepared by placing one part  
STS (or the detergent agent of choice) in one syringe to four parts air in 
the other syringe. The syringes are attached to stopcock, the stopcock is 
closed  off,  and  the  foam  solution  is  created  by  a  rapidly  mixing  the  air  
and chemical back and forth between the two syringes. This rapid 
movement of solution from one syringe to other is performed 20 times. 
After moving most of the solution to one syringe, the filled syringe is 
connected to the needle, and intravascular positioning is reconfirmed with 
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ultrasound. A small amount of foam should be injected initially to 
confirm needle placement within the vein under ultrasound. The amount 
of foam delivered is determined during injection by using ultrasound to 
visualize when the targeted vein is filled with foam. On completion the 
needle is removed, and folded 2 ý 2-inch gauze is secured over the 
injection site with adhesive tape. 
Discharge and Follow-up 
Recent studies have demonstrated increased efficacy with post  
procedure compression. Weiss and coworkers evaluated various lengths 
of compression and found a strong correlation between compression time 
and efficacy, as well as side effects; patients undergoing 3 weeks of 
continuous compression demonstrated the most improvement. 
Subsequent to ambulation, patients can be discharged from the facility. 
They may return to activities of daily living but should avoid heavy 
aerobic exercise that would involve the lower extremities for a period of 2 
weeks.  
Complications 
Complications typically includes hyperpigmentation, telangiectatic 
matting, pain with injection, and urtication after injection.  
Rarely observed are more serious complications, including but perhaps 
not limited to cutaneous necrosis, superficial thrombophlebitis, nerve 
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damage (saphenous, sural), allergic reaction (anaphylaxis), DVT, 
pulmonary embolism, and inadvertent arterial injection. 
TREATMENT OF PERFORATOR VEIN INCOMPETENCE 
The recent development of treatment options for reflux in 
superficial veins has established new standards for when patients can be 
treated as outpatient without the need for general anesthesia. These 
treatment options allow patients to ambulate immediately after treatment 
with less postoperative pain and almost no negative impact on quality of 
life. In this new environment, the invasiveness and risk for wound 
complications associated with previously considered minimally invasive 
SEPS exceed that of the treatment of saphenous veins. New modalities 
such as ultrasound-guided percutaneous ablation of perforating veins with 
sclerosing solutions or thermal energy are becoming increasingly popular. 
During such a short history, the outcomes of IPV treatment and the 
role of IPVs in venous pathology were questioned and disputed. Although 
evidence provides a substantial basis for decision making in management 
of patients with varicose veins, it would be fair to state that the impact of 
IPVs on the natural history of varicose veins and the indications for 
elimination of PV reflux remain to be defined more precisely. 
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INDICATIONS FOR INTERRUPTION 
Precise definition of the indications for interruption of perforator 
incompetence is necessary in clinical practice because it provides a basis 
for assessment of treatment outcomes. Although definitive studies to 
identify when IPV interruption should be considered are yet to be 
conducted,  one  or  more  of  the  following  reasons  can  serve  as  the  
indication for treatment of IPVs. 
 
1. Promotion of ulcer healing in extremities with CEAP clinical 
class C6 
 
2. Prevention of ulcer recurrence in extremities with clinical classes 
C5 and C6 
 
3. Diminution of the severity of CVD and resolution of symptoms in 
C2S to C5S extremities 
 
4. Prevention of progression to more advanced stages in C2 to C4 
extremities. 
 
The presence of an IPV alone does not justify interruption. The 
decision to intervene should be based on clinical judgment and 
assessment of the role of a specific IPV in the overall hemodynamic 
picture  of  the  extremity.  The  benefits  of  interruption  and  the  risks  of  
leaving this PV untreated should also be considered. 
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OPERATIVE PLANNING AND OPTIONS 
The timing and technique of IPV interruption are important. 
Although procedures can be staged, performing simultaneous saphenous 
vein ablation and perforator ablation has two major advantages. First, all 
invasive procedures are performed in one session, which is highly 
appreciable by the patient. Second, it has been suggested that any 
remaining incompetent tributaries and IPVs connected to the saphenous 
veins can increase the chance of recanalization after thermal and chemical 
ablation. Thus, treating IPVs at the time of saphenous vein ablation 
possibly improves the result of the saphenous vein ablation. When 
simultaneous treatment of IPVs and incompetent saphenous veins is 
planned, selection of the IPV interruption technique is very much 
dependent on the method of treating the saphenous vein. The less 
invasive options for saphenous ablation limit the use of open surgical 
interruption because it may increase immediate postoperative morbidity 
and negate the advantages of minimally invasive procedures. When IPV 
interruption is performed alone, selecting a minimally invasive option 
still has the advantage of minimizing immediate postoperative morbidity 
and thereby allowing early ambulation and having less of an impact on 
quality of life. 
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OPEN SURGERY 
Interruption of PVs through small stab wounds plus avulsion by a 
vein hook is now preferred among the open surgical methods because this 
procedure is significantly less invasive and does not require 
hospitalization. With this technique, duplex scanning is used for 
preoperative mapping and the IPVs are marked on the skin, which allows 
performance of a more precise procedure. Ligation of incompetent 
perforators can also be done by making a short incision directly over the 
marked sites and ligating them at the fascia with absorbable sutures. 
Alternatively, vein hook position can be controlled with the use of 
intraoperative  transcutaneous ultrasound to ensure that a targeted IPV is 
actually interrupted. Selection of an open perforator interruption 
technique does not guarantee 100% success. Five percent of perforators 
are usually missed, and 32% recur within 3 years, half of them being 
incompetent. 
  
69 
 
Subfascial Endoscopic Perforator Surgery 
 
SEPS uses endoscopic instrumentation to achieve interruption of 
incompetent perforators through small incisions placed remotely from 
areas of lipodermatosclerosis or ulceration. First described by Hauer in 
the 1980s. SEPS became the most accepted surgical treatment of 
advanced stages of chronic venous insufficiency because of its minimally 
invasive nature and safety profile when compared with the classic, more 
extensive Linton procedure. SEPS can be performed through one or two 
endoscopic ports; the two-port technique uses a 10-mm port for the 
camera and a 5-mm port for the instrumentation. Adding the second  
5-mm port is favored by most authors because it does not significantly 
increase the morbidity of the procedure, and it facilitates work in the 
narrow subfascial space. The limb is elevated and rested on a leg holder, 
the field is made bloodless by exsanguination of the limb with an 
Esmarch bandage, and a thigh tourniquet is inflated to 300 mm Hg. The 
10-mm port is placed in healthy skin on the medial aspect of the calf, 
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10 cm distal to the tibial tuberosity. A small longitudinal skin incision is 
performed first and the subcutaneous tissues are sharply dissected until 
the fascia is encountered; the fascia is then grasped with mosquito clamps 
and incised longitudinally as well. Care must be taken to avoid creating 
too large an opening because this may lead to gas leak during the 
procedure and consequently poor visualization. Balloon dissection may 
be used to facilitate passage through the subfascial space and help with 
initial access through the ports. The camera is inserted through the first 
port, and then a second 5-mm port is inserted under vision about 10 to 
12 cm distal and posterior to the first port, halfway between the main port 
and the ankle. Carbon dioxide is insufflated to enlarge and optimally 
visualize the subfascial space, with pressure maintained around 
30 mm Hg. Initial tissue dissection is performed with endoscopic scissors 
inserted  through  5-mm  port,  and  the  areolar  tissue  between  the  calf  
muscles and the superficial fascia is sharply divided. All visualized 
perforators encountered from the medial border of the tibia to the 
posterior midline are interrupted with one's preferred technique, such as 
the harmonic scalpel, electrocautery, or division with scissors between 
metallic clips. A sharp paratibial fasciotomy should routinely be 
performed before identification and division of the perforators because 
the posterior tibial perforators are often located in the deep posterior 
compartment, behind paratibial fascia or within the intermuscular septum. 
More proximal paratibial perforators may be visualized better by 
exposing the medial insertion of soleus muscle on the tibia. It is important 
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during this step to remain close to tibia to avoid injury to the posterior 
tibial vessels and the tibial nerve. A technical limitation is the presence of 
retromalleolar perforators, which cannot be reached this way and need to 
be treated by an open technique with a separate incision. On completion 
of the procedure, the ports and instrumentation are removed, the 
tourniquet  is  deflated,  and  the  CO2 is manually expressed from the 
subfascial space. If varicose stab avulsions are performed at the same 
time as SEPS, the tourniquet is kept inflated to control bleeding. A 
compressive bandage is applied, and patients can be discharged after a 
few hours of observation. 
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MATERIALS AND METHODS 
 Around 60 patients with varicose veins will be selected from the 
patients attending out-patient clinic in Rajiv Gandhi Govt. General 
Hospital, Madras Medical College. All patients will be explained about 
the disease, benefits & possible side effects of treatment. Informed 
written consent will be obtained from all patients before initiation of 
treatment. Detailed history will be obtained and patients will be evaluated 
as follows  
1)  General and systemic examination. 
2)  Investigations namely complete hemogram, liver function tests, 
renal function tests and chest xray.  
3)  Abdominal Ultrasound, Doppler study of both lowerlimbs (arterial 
& venous) 
The study will be prospective hospital based time boundstudy. All 
those cases which satisfy the inclusion criteria will be included in this 
study. Duration of study will be from June 2015 to Sept. 2015.  
Inpatients  of  Rajiv  Gandhi  Govt.  General  Hospital  who  are  
undergoing elective varicose vein surgery fulfilling the inclusion criteria 
will be taken into study after obtaining informed written consent.  
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The cases will be randomly divided in three groups, based on the 
mode of management for SFJ incompetence. 
   Group-A patients will be treated with high ligation of great 
saphenous vein.   
Group-B patients will be treated with ligation of great saphenous 
vein along with stripping from groin to knee and  
Group-C  patients  will  be  treated  with  Radiofrequency  ablation  of  
great saphenous vein.  
In all three groups perforators incompetence will be managed with 
stab avulsion  
SUBJECT SELECTION: 
INCLUSION CRITERIA:   
1. Patients who have given informed and written consent. 
2. Age of the patient: 18 -50 years. 
3. Primary varicose veins. 
EXCLUSION CRITERIA:  
1. Age <18years or age > 50 years. 
2. Secondary varicose veins. 
3. Patients with venous ulcer. 
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SCREENING PROCEDURES / VISITS: 
 Patients will be reviewed immediate postoperatively,  after 6 weeks 
and 3 months after surgical procedure 
Following factors will be compared…. 
 Duration of Procedure 
 Post operative pain score 
 Limb oedema  
 Wound infection 
 Duration of hospital stay 
 Localized haematoma & Skin changes 
RESULTS: 
 Statistical analysis plan: Data obtained will be analysed using 
appropriate statistical package with due consultation with the Statistician. 
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OBSERVATION AND ANALYSIS 
 
 
 
AGE DISTRIBUTION 
 
AGE GROUP (years) NO. OF PATIENTS 
18-25 8 
26-30 7 
31-35 13 
36-40 19 
41-45 9 
46-50 4 
 
 
 
Sex Distribution 
 
Male     -  42 
Female -  18 
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As per the age is concerned, most of the patients in this study are 
between 30-40 years old and considering sex, two-third of the patients are 
males. 
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Duration of Procedure:   
In patients treated with flush ligation of GSV alone, mean time 
duration was around 45 minutes. In case of patients treated with Ligation 
and stripping of GSV, mean time duration was 55 minutes, but in patients 
treated with RFA of GSV, mean time duration was 32 minutes only. 
 
 
 
 
 
Post operative pain score:  
Post op pain score was calculated by Visual Analog Scale with ‘0’ 
as no pain and 10 as maximum pain.  In patients  treated with ligation of  
GSV alone mean pain score was 4.3. In case of ligation and stripping of 
GSV, mean pain score was 5.2 and in RFA of GSV, it was 2.2.  
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Limb Oedema:  
Oedema of operated limb developed in 2 cases treated with ligation 
of GSV alone, 3 cases of ligation and stripping of GSV and none of the 
patients treated with RFA developed limb oedema. 
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Wound infection:  
In case of patients treated with ligation of GSV alone 3 patients 
developed wound infection, 5 patients developed wound infection in 
patients treated with ligation and stripping of GSV and only 1 patient 
developed wound infection at the catheter inserted site in RFA category. 
 
 
 
 
Duration of Hospital stay:  
 
In case of patients treated with ligation of GSV alone, mean 
hospital duration of stay was 5.4 days. In patients with ligation and 
stripping of GSV, mean hospital duration of stay was 6.2 days including 
the pre op evaluation and assessment work up in both cases. But in 
patients treated with RFA, mean hospital duration was only 1.8 days. 
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Localized Haematoma & Skin Changes:  
Localized haematoma developed in 3 patients treated with Ligation 
of  GSV alone,  4  patients  of  ligation  and  stripping  of  GSV,  but  none  of  
RFA patients developed localized haematoma and any type of skin 
changes. 
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DISCUSSION 
 
In duration of procedure, we haven’t included the anaesthetic 
preloading or induction time in any of three categories. As we use 
CLOSURE FAST RFA device, it does segmental ablation, so patients 
treated with RFA comparatively less procedure time than patients treated 
with ligation of GSV alone and ligation and stripping of GSV. 
Considering Post operative pain score, Patients treated with 
conventional surgery needed IM voveran on post op day 1 and 2 
sometimes, but patients treated with RFA needed only oral analgesics. 
In case of limb oedema of operated limb, RFA patients in this 
study did not have any limb oedema, but some of the patients treated with 
conventional surgery developed  limb oedema which needed tight 
compression stockings, limb elevation and sometimes even anti oedema 
measures. 
Wound infection: In conventional surgery cases, some patients 
developed wound infection, which was considered to be due to poor 
preparation of operative site, localized fungal infections and poor post op 
wound care. But in RFA patients, only one patient developed wound 
infection at catheter insertion site. 
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Duration of hospital stay: It was comparatively longer in patients 
treated with conventional surgery as those patients needed detailed lab 
investigations, pre op evaluation and assessment work up. But RFA 
patients needed only pre op Duplex scan and anaesthetic fitness. 
Localized Haematoma & skin changes: This was developed only 
in patients treated with conventional surgery and probably the same cause 
was attributed as in wound infection cases. 
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CONCLUSION 
 
RFA is a minimally invasive procedure. Its potential early benefits, 
by avoiding groin dissection and GSV stripping, have been confirmed by 
the findings from this study.  
Patients experienced less pain and recovered more quickly, which 
was reflected in better patient satisfaction and Quality of life outcomes 
following RFA.  
RFA involves considerably less tissue dissection and trauma. 
Patients who had RFA experienced considerably less pain, required less 
analgesia and were able to return to their activities more quickly. This 
improved confidence, lifestyle, social contacts, cosmesis, QoL and 
satisfaction in the early days after RFA procedure can be considered 
significantly better than in patients undergoing conventional surgery. 
The most common reason for dissatisfaction was postoperative 
morbidity, after conventional surgery illustrating the impact of adverse 
sequelae. QoL was significantly better after both interventions. Scores 
were, however, consistently higher after RFA.   
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PROFORMA 
 
PATIENT DETAILS: 
 
Name:     Age:    Sex:    
 
IP No. : 
 
ON ADMISSION: 
Main Complaints : 
 
Duration of Complaints : 
 
Co – Morbid Illness  : 
 
Significant Past History : 
 
CLINICAL EXAMINATION: 
Pulse :     BP : 
RR :      Temp : 
Pallor :     Icterus : 
 
CVS  :     RS : 
 
P/A : 
L/E: 
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INVESTIGATIONS : 
CBC:      ESR: 
Liver Function Test  :   Renal Function Test : 
CXR : 
USG Abdomen: 
Doppler Lower limb: 
 
TREATMENT : 
 
Post operative complications: 
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